Dotmatics aims to speed drug development and break data silos with Geneious Luma
Dotmatics has launched Geneious Luma, an AI-driven platform featured in VentureBeat, designed to accelerate drug discovery by streamlining workflows, integrating data to eliminate silos, and enabling biopharma researchers to uncover insights faster for improved therapeutic development.
Dotmatics is transforming drug discovery and development with the launch of Geneious Luma, as featured in VentureBeat. This cutting-edge AI platform is designed to speed up workflows and streamline data integration in biopharma research. With its ability to eliminate data silos, Geneious Luma enables researchers to uncover insights faster, driving significant improvements in therapeutic discovery.
Geneious Luma leverages AI to unlock new possibilities in drug development, helping researchers accelerate their processes and improve outcomes.
Related
Limitations of Existing Life Science Software—and the Opportunity to Evolve
Existing life science software tools like ELNs, LIMS, and SDMS, while essential for digitizing workflows and managing data, are limited by their siloed, non-real-time, and non-AI-integrated designs, presenting an opportunity to evolve by integrating them into unified, intelligent platforms—such as Dotmatics Luma—that enable connected, workflow-aware, multimodal scientific intelligence with adaptive workflows, real-time data flow, and cross-functional insights without replacing core systems.
Data Evolution in Pharma: The Spread of Multimodal
The pharmaceutical industry is shifting from single-mode to multimodal drug discovery, incorporating diverse therapeutic modalities like biologics, gene therapies, and small molecules, but this evolution presents significant challenges in integrating heterogeneous R&D data and technologies, necessitating advanced, compatible platforms to enable efficient collaboration and leverage AI-driven insights for faster, cost-effective drug development.
3 Customer Trends We’re Watching in 2025
In 2025, life science teams are prioritizing three key trends—Lab-in-a-Loop platforms that integrate instruments, data, workflows, and models to boost R&D efficiency; true multimodal discovery enabled by flexible informatics supporting diverse data types without fragmented tools; and Composite AI leveraging layered, governed, and traceable data across disciplines—all aimed at delivering tangible scientific innovation while addressing resource constraints and stringent AI governance requirements.
From Data Silos to AI-Ready Science: The Vision Behind Dotmatics Luma
Dotmatics Luma is a new, AI-driven, multimodal scientific platform designed to overcome data silos and fragmented R&D systems by uniting diverse scientific software and streamlining workflows across biologics, small molecule, and materials discovery, enabling smarter, faster, and more collaborative drug discovery and therapeutics development at the enterprise level.
The Rise of Multimodal R&D and AI in Driving Pharma Innovation
The ebook "The Rise of Multimodal R&D and AI in Driving Pharma Innovation" explains how Dotmatics' Luma platform integrates diverse scientific data and leverages AI to overcome challenges like high costs and data silos, enabling pharmaceutical and biotech companies to accelerate drug discovery, enhance collaboration, and prepare for an AI-driven future in research and development.
How Luma Lab Connect Automates Lab Data Acquisition Across 100+ Instruments
Dotmatics Luma Lab Connect, part of the Dotmatics Luma multimodal scientific R&D platform, automates and streamlines the acquisition, management, and preparation of complex, multimodal lab data from over 100 diverse instruments and sources, addressing challenges of data security, integrity, and usability to enhance research productivity and enable FAIR data practices within a unified, low-code SaaS environment.